News archive search

Search the Newsreel

Search stored headlines and summaries, then narrow the results by company, country, sector, industry, source or date.

Showing
181–216
Matches
7255
Sources here
24
Companies here
30
Search results Stored financial headlines

Active search

7255 matching headlines

Ticker or company: ACEMain company stories
Clear

Search results

Matching headlines

External headlines link to their original source. Market context comes from stored weekly company data, not from an opinion about the article.

REGN Stockholders Interested in Leading the Class Action Against Regeneron Pharmaceuticals, Inc. Should Contact Robbins LLP for Information About Recovering Their Losses

Robbins LLP is reminding investors that a securities class action lawsuit has been filed against Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN). The lawsuit alleges that Regeneron misled investors about its Phase 3 Fianlimab-Libtayo clinical trial for advanced melanoma, specifically regarding statistical assumptions and clinical differentiation. …

REGN main company
Sharemaestro market context Price above Trend Line 52 weeks +36.8% REGN stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Why Regeneron (REGN) Is Up 5.4% After FDA Approves Pasatru For Ultra-Rare FOP Therapy

In August 2026, Regeneron Pharmaceuticals announced that the US FDA approved Pasatru (garetosmab-grts) to reduce new heterotopic ossification lesions and flare-ups in adults with fibrodysplasia ossificans progressiva, based on positive Phase 3 OPTIMA trial results. This approval adds a rare-disease monoclonal antibody to Regeneron's …

REGN main company REGN34 main company REGN main company RGO main company REGN main company
Sharemaestro market context Price above Trend Line 52 weeks +24.3% · Next-week setup negative 36.4% REGN stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Extra Space Storage declares $1.62 dividend for Q3 2025, payable Sept 30 to shareholders of record Sept 15.

Extra Space Storage Inc. (EXR) has declared a dividend of $1.62 per share for the third quarter of 2025. This dividend is scheduled to be paid on September 30, 2025, to shareholders who are on record by September 15, 2025. The company, which is …

EXR main company
Sharemaestro market context Trend signal active 52 weeks +8.5% EXR stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Regeneron (REGN) Stock Looks Undervalued On Expanded Cancer Collaboration News

Never miss an important update on your stock portfolio and cut through the noise. Over 7 million investors trust Simply Wall St to stay informed where it matters for FREE. Regeneron Pharmaceuticals stock has delivered a 43.0% return over the past year, yet the …

REGN main company REGN34 main company REGN main company RGO main company REGN main company
Sharemaestro market context Price above Trend Line 52 weeks +24.3% · Next-week setup negative 36.4% REGN stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Mirum Pharmaceuticals(MIRM.US) Officer Sells US$4 Million in Common Stock

A Mirum Pharmaceuticals officer recently sold common stock valued at approximately $4 million. This transaction indicates a significant insider sale at the company.

MIRM main company
Sharemaestro market context Trend signal active 52 weeks +40.7% · Next-week setup positive 56.4% MIRM stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Amylyx Pharmaceuticals Announces Pricing of an Upsized $500 Million Underwritten Public Offering of Common Stock

Amylyx Pharmaceuticals has announced the pricing of an upsized underwritten public offering of 14,090,000 shares of its common stock at $35.50 per share, aiming to raise $500.2 million before deductions. The company plans to use the net proceeds for pre-commercial activities for avexitide, research …

AMLX main company
Sharemaestro market context Trend signal active 52 weeks +132.6% · Next-week setup positive 55.7% AMLX stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Telix Pharmaceuticals (ASX:TLX) Shares Rise Today as H1 Revenue Climbs 22% to US$477 Million

Telix Pharmaceuticals (ASX:TLX) saw its shares rise as it reported a 22% increase in H1 2026 revenue to US$477 million, with a gross margin of 55%. Adjusted EBITDA surged by 146% to US$52 million, and the company achieved a profit after tax of US$38 …

REGN main company TLX main company TLX main company
Sharemaestro market context Price above Trend Line 52 weeks +36.8% REGN stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Does UHS’s Debt-Funded Talkspace Deal Reshape the Bull Case For Its Digital Behavioral Health Pivot?

Universal Health Services (UHS) recently acquired Talkspace, funding it with significant debt. This move into digital behavioral health raises questions about the company's investment narrative, given the increased financial leverage and softening earnings forecasts. The article discusses the implications of this debt-funded acquisition on …

TALK main company
Sharemaestro market context Trend signal active 52 weeks +87.5% TALK stored weekly price path from 22 Aug 2025 to 14 Aug 2026

AST SpaceMobile (NASDAQ: ASTS) CTO adds 40,000 shares via option exercise

AST SpaceMobile's CTO, Huiwen Yao, exercised 40,000 AST LLC Incentive Equity Options on August 19, 2026, at an exercise price of $0.0641 per share, increasing direct ownership to 74,750 shares of Class A Common Stock. This transaction reduced his derivative position to 219,912 units. …

ASTS main company
Sharemaestro market context Price below Trend Line 52 weeks +50.8% ASTS stored weekly price path from 22 Aug 2025 to 14 Aug 2026

AST SpaceMobile (ASTS) grants CFO 75,000 RSUs with multi-year vesting

AST SpaceMobile, Inc. (ASTS) has granted its CFO and Chief Legal Officer, Andrew Martin Johnson, 75,000 restricted stock units (RSUs). These RSUs will vest in three equal installments over three years, starting from May 30, 2026, contingent on his continued service. Following this grant, …

ASTS main company
Sharemaestro market context Price below Trend Line 52 weeks +50.8% ASTS stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Telix Pharmaceuticals delivers robust half-year earnings and pipeline progress

Telix Pharmaceuticals (ASX: TLX) reported robust half-year results, with revenue up 22% to US$477 million and adjusted EBITDA surging 146% to US$52 million. The company made significant progress in pipeline development, strategic collaborations, and global manufacturing expansion. Telix reaffirmed its FY26 revenue guidance of …

REGN main company
Sharemaestro market context Price above Trend Line 52 weeks +36.8% REGN stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Geospace delivers 4,000 Pioneer seismic nodes to Faraday Geophysics in repeat order

Geospace has delivered 4,000 Pioneer land seismic acquisition nodes to Faraday Geophysics, marking a repeat purchase that increases Faraday's owned fleet to 7,000 nodes. Faraday aims to further expand its inventory to 10,000 nodes by November 2026 and eventually build a 40,000-node fleet by …

GEOS main company
Sharemaestro market context Price below Trend Line 52 weeks -71.3% GEOS stored weekly price path from 22 Aug 2025 to 14 Aug 2026

RXT INVESTOR REMINDER: Rackspace Technology, Inc. Investors Have Until September 28, 2026 To Contact Kirby McInerney LLP to Seek Lead Plaintiff Role

Kirby McInerney LLP reminds investors of Rackspace Technology, Inc. (NASDAQ: RXT) that they have until September 28, 2026, to seek the lead plaintiff role in a securities fraud class action lawsuit. The lawsuit alleges Rackspace made misleading statements regarding its enterprise AI efforts, declining …

RXT main company
Sharemaestro market context Trend signal active 52 weeks +221.4% RXT stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Mirum Pharmaceuticals (MIRM) SVP exercises 40k options, sells shares

Jolanda Howe, SVP, Global Controller at Mirum Pharmaceuticals (MIRM), exercised 40,000 employee stock options at $6.27 per share and subsequently sold all 40,000 common shares at $100.00 per share on August 18, 2026. This transaction resulted in an approximate pre-tax spread of $3.75 million. …

MIRM main company
Sharemaestro market context Trend signal active 52 weeks +40.7% · Next-week setup positive 56.4% MIRM stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Telix 2026 Half-Year Results: Strong Commercial Execution and Momentum in Late-Stage Pipeline

Telix Pharmaceuticals Limited MELBOURNE, Australia and INDIANAPOLIS, Aug. 20, 2026 (GLOBE NEWSWIRE) -- Telix Pharmaceuticals Limited (ASX: TLX, NASDAQ: TLX, "Telix") today announces its financial results for the period ended June 30, 2026. H1 2026 key results Group performance1: Double-digit revenue growth and gross …

TLX main company TLX main company
Sharemaestro market context Trend signal active 52 weeks -8.7% TLX stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Find financial news

Search the Newsreel

Use one field or combine several. Results are newest first.

Evidence context